November 20, 2024

CPPD Disease: More Common Than Previously Thought

In a paradigm shift for treating acute CPPD crystal arthritis, the 2023 COLCHICORT trial showed prednisone matched colchicine's efficacy with better tolerability in older patients, challenging long-held treatment assumptions.

Conexiant

November 20, 2024

CPPD Disease: More Common Than Previously Thought

In a paradigm shift for treating acute CPPD crystal arthritis, the 2023 COLCHICORT trial showed prednisone matched colchicine's efficacy with better tolerability in older patients, challenging long-held treatment assumptions.

Conexiant

November 19, 2024

Can High Dose Buprenorphine Improve Fentanyl OUD Outcomes?

Conexiant

November 15, 2024

Global Study Finds Pruritus Affects 40% of Adults Worldwide

Patients with skin conditions are three times more likely to experience pruritus, highlighting a critical link between dermatologic health and quality of life.

Conexiant

November 13, 2024

Baltimore Secures $266M in Opioid Case

Reuters

November 13, 2024

Methadone, Buprenorphine Equal in New Guidelines

Meta-analyses showed both methadone and buprenorphine cut mortality risk in half compared to no treatment, marking a significant shift in Canadian guidelines that now recommend them as equal first-line options for opioid use disorder.

Conexiant

November 13, 2024

Are Key Patient Concerns Going Undocumented?

When clinicians initiated psychosocial discussions, 92% appeared in notes, but when patients raised these concerns, only 45% were documented.

Conexiant

November 11, 2024

AF Burden Trends Linked to Stroke Risk

Temporal AF burden trends offer a novel edge in stroke prediction, outperforming traditional risk scores with a predictive AUC of 0.726 for ischemic events, a new study finds.

Conexiant

November 08, 2024

Why to Consider Age in IBS Management

Age-related reductions in visceral sensitivity and slower colonic transit may be associated with variations in symptom presentation.

Conexiant